Kento Health is a technology company.
Kento Health has raised $6.0M across 1 funding round.
Kento Health has raised $6.0M in total across 1 funding round.
Kento Health has raised $6.0M in total across 1 funding round.
Kento Health's investors include Boreal Ventures, Harvest Venture Partners, Highline Beta Inc., High Line Venture Partners, N49P Ventures.
# Kento Health: High-Level Overview
Kento Health is an AI-powered digital cardiac rehabilitation and heart care platform that helps patients recover from major cardiac events and manage cardiovascular diseases[1]. Founded in 2022 and based in Montreal, Canada, the company serves health systems, providers, health plans, employers, and patients directly[1].
The platform delivers personalized clinical exercise plans, real-time heart monitoring, coaching, and continuous care coordination through a combination of AI-driven personalization and certified specialist support[2]. Kento's core value proposition centers on improving patient outcomes while reducing hospitalizations and expanding revenue opportunities for health systems—the company reports up to 3x higher enrollment rates, 95% adherence, and up to 2.5x ROI from expanded cardiac programs[2].
# Origin Story
Kento Health emerged in 2022 as a response to gaps in cardiac rehabilitation accessibility and engagement. The company distinguished itself early through a strategic partnership with Mayo Clinic, which co-developed the platform[4]. This partnership provided clinical credibility and domain expertise that shaped the product's architecture from inception. The company closed a $4.1 million CAD ($3 million USD) pre-seed financing round, signaling investor confidence in the digital cardiac care market[1].
# Core Differentiators
# Role in the Broader Tech Landscape
Kento operates within the digital health transformation trend, specifically addressing the shift toward remote monitoring and continuous care models. The timing is critical: health systems face mounting pressure to reduce readmissions, improve HEDIS/Star ratings, and expand revenue through value-based care models. Kento's AI-driven approach aligns with broader healthcare industry movement toward personalized medicine and home-based care delivery.
The company also reflects growing recognition that chronic disease management requires behavioral engagement, not just clinical intervention. By combining real-time monitoring with AI-powered personalization and human coaching, Kento addresses a market gap where traditional cardiac rehabilitation programs struggle with enrollment and adherence. Its success influences how health systems think about scaling specialized care programs beyond traditional in-clinic models.
# Quick Take & Future Outlook
Kento Health is positioned at the intersection of three powerful trends: the shift to remote care, the adoption of AI in clinical decision-making, and the healthcare industry's focus on reducing preventable hospitalizations. The company's early traction—demonstrated through health system partnerships and measurable outcome improvements—suggests strong product-market fit in a high-stakes clinical domain.
Looking forward, Kento's growth will likely depend on expanding beyond cardiac rehabilitation into broader cardiovascular disease management and chronic condition monitoring. The Mayo Clinic partnership provides a foundation for clinical validation that could accelerate adoption across larger health systems. As value-based care models become standard, platforms that demonstrably reduce readmissions and improve outcomes while improving operational efficiency will become essential infrastructure rather than optional tools.
Kento Health has raised $6.0M across 1 funding round. Most recently, it raised $6.0M Seed in October 2023.
| Date | Round | Lead Investors | Other Investors |
|---|---|---|---|
| Oct 1, 2023 | $6.0M Seed | Boreal Ventures, Harvest Venture Partners, Highline Beta Inc., High Line Venture Partners, N49P Ventures |